United States: Understanding Medical Foods Under FDA Regulations

Last Updated: April 2 2014
Article by Claudia Lewis and Michelle C. Jackson


It took the Food and Drug Administration (FDA) 50 years after the passage of the Federal Food, Drug, and Cosmetic Act (FDCA) to formally define "medical foods." Prior to 1972, what we now would consider medical foods were regulated as prescription drugs under section 201(g)(1)(B) of the FDCA because of their role in mitigating serious adverse effects of diseases.1 Furthermore, prior to 1972, to market new products, manufacturers of medical foods were subject to onerous requirements, such as conducting complete drug trials, Investigational New Drug license applications, and New Drug Applications. Extremely time-consuming and cost-restrictive, such requirements choked the life out of medical food product innovation.

In 1972, the FDA reassessed its position on medical foods. This action was prompted by the agency's interest in fostering innovation in the development of medical foods and ensuring that such products were available to the public at a reasonable cost. However, due to safety concerns, the agency still sought to differentiate medical foods from general use foods. For example, the FDA reasoned that Lofenalac, an infant product designed for use in the dietary management of a rare genetic condition known as phenylketonuria (PKU), would be hazardous for healthy infants since it would be nutritionally inadequate for them. Therefore, the agency reclassified medical foods provided enterally (i.e., ingested via the digestive tract) as "foods for special dietary use," but injectable medical foods remained classified as drugs subject to the FDA's Drug Efficacy Study (DESI) program.2 In short, enterally administered nutrition was transferred to the food category while parenteral nutrition (i.e., injected into the body) retained its drug status.

Just one year later, when the agency made nutrition labeling mandatory for certain foods, it exempted certain types of foods for special dietary use from this requirement.3 In the preamble of the final rule, the FDA noted that nutrition labeling developed for foods intended for consumption by the general population was not well suited for some food products. Two foods for special dietary use were exempted from the nutrition labeling required for other food: (1) any food represented for use as the sole item of the diet and (2) foods represented for use solely under medical supervision in the dietary management of specific diseases and disorders.

A statutory definition of medical foods was finally promulgated in the Orphan Drug Amendments of 1988, Section 5b, Orphan Drug Act.4 A medical food was defined as "a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation."5 This statutory definition remains unchanged. Unfortunately, the legislative history of the amendments does not discuss the statutory definition of medical foods, thus failing to provide any additional information regarding the types of products Congress intended the definition to cover.6

Soon after the Orphan Drug Act Amendments, the FDA formally launched its initiative to improve the content and format of food labels with the publication of an Advanced Notice of Proposed Rulemaking (ANPR).7 As part of this overall initiative, the agency sought to resolve consumer confusion about food labels, aid consumers in health food decisions, and encourage product innovations so that manufacturers were given an incentive to improve the quality of the food and provide consumers with more healthy food choices.8 In the ANPR, the FDA asked the industry for guidance on a wide range of food-labeling issues to assist the agency in determining what, if any, changes to food labeling requirements were necessary, and it was quickly followed by four public hearings. With obvious public support for a thorough modernization of food labeling, the FDA published proposed regulations on July 19, 1990.9

It was during the comment period for the proposed regulations that Congress passed the Nutrition Labeling and Education Act of 1990 (NLEA), and on November 8, 1990, the legislation was signed into law by President George H. Bush. Not only did the NLEA affirm the FDA's authority to mandate nutrition labeling on most foods and clarify the agency's role in regulating nutrient content claims and health claims on food labels, it also incorporated the definition of medical foods contained in the Orphan Drug Amendments of 1988 into Section 403(q)(5)(A)(iv) of the FDCA and exempted medical foods from the nutrition labeling, health claim, and nutrient content claim requirements applicable to foods generally.10

Quickly thereafter, the FDA published a proposal to implement the mandatory nutrition labeling provisions of the NLEA, focusing specifically on the statutory exemption for medical foods.11 The proposal advised that the agency considered the statutory definition of medical foods to "narrowly constrain the types of products that can be considered to fall within this exemption,"12 a sentiment that the FDA has since reiterated time and again. Further, the FDA explained how medical foods are distinguished from the broader category of foods for special dietary use and from foods that make health claims. In the FDA's opinion, "under the supervision of a physician" within the NLEA meant "that the intended use of a medical food is for the dietary management of a patient receiving active and ongoing medical supervisions (e.g., in a health care facility or as an outpatient). The physician determines the food that is necessary to the patient's overall medical care,"13 and the patient visits the doctor for instructions on the use of the medical food. In its closing remarks on medical foods, the FDA stressed the vital public health interest in proper labeling of the nutrient content and purported uses of medical foods, which it noted may require a different manner and more detail than more traditional foods, adequate and appropriate directions for use, and product quality assurance. Thus, the agency declared that it intended to develop regulations covering these aspects "in the near future."14

In the Federal Register of January 6, 1993, the FDA published the final rule on mandatory nutrition labeling, which exempted medical foods from the nutrition labeling requirements and incorporated the statutory definition of medical foods into the agency's regulations at Section 101.9(j)(8).15 In the regulation, the FDA enumerated criteria intended to clarify the characteristics of medical foods. Accordingly, a food was defined as a medical food and, thus, not subject to the nutrition labeling requirements only if:

  1. It is a specially formulated and processed product (as opposed to a naturally occurring foodstuff used in its natural state) for the partial or exclusive feeding of a patient by means of oral intake or enteral feeding tube.
  2. It is intended for the dietary management of a patient who, because of therapeutic or chronic medical needs, has limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements, the dietary management of which cannot be achieved by the modification of the normal diet alone.
  3. It provides nutritional support specifically modified for the management of the unique nutrient needs that result from the specific disease or condition, as determined by medical evaluation.
  4. It is intended to be used under medical supervision.
  5. It is intended only for a patient receiving active and ongoing medical supervision wherein the patient requires medical care on a recurring basis for, among other things, instructions on the use of the medical food.16

This definition remains unchanged. In addition, the agency acknowledged that further clarification on the specific types of products the FDA considers medical foods would be helpful. Accordingly, it expressed its intention to address the issue in the future, but also noted its objective to develop much-needed medical food-labeling regulations.17

Citing the enactment of a statutory definition of medical food, the rapid increase in the variety and number of products marketed as medical foods, safety problems associated with the manufacture and quality control of these products, and the potential proliferation of fraudulent claims not supported by sound science, the FDA issued an ANPR on the "Regulation of Medical Foods" in 1996.18 The agency also sought to clarify the distinct differences between medical foods and foods for special dietary purpose. Though this ANPR was withdrawn in 2004, it largely remains the guiding force for industry understanding of the agency's views of medical food regulation.19

In the 1996 ANPR, the FDA acknowledged that the universe of products purporting to be medical foods had surpassed the statutory definition of a medical food to include foods that would more appropriately be categorized as foods for special dietary use. Looking to statutory language, the FDA sought to outline distinctions between these two types of foods, beginning with the meaning of "distinctive nutritional requirements" in the FDCA's definition of medical food. Pursuant to the statute, distinctive nutritional requirements must be based on recognized scientific principles and established by medical evaluation. Unfortunately, as the FDA noted in the ANPRM, the law does not define distinctive nutritional requirements. As a result, the agency proposed two possible interpretations of the phrase: (1) physiological interpretation and (2) alternative interpretation.

In the physiological interpretation, the FDA advised that distinctive nutritional requirements could be understood as referring to the body's need for specific amounts of nutrients to maintain homeostasis and sustain life. Under this interpretation, medical foods are

foods that are formulated to aid in the dietary management of a specific disease or health-related condition that causes distinctive nutritional requirements that are different from the nutritional requirements of healthy people. Foods for special dietary use, on the other hand, are foods that are specially formulated to meet a special dietary need, such as a food allergy or difficulty in swallowing, but that provide nutrients intended to meet ordinary nutritional requirements. The special dietary needs addressed by these foods do not reflect a nutritional problem per se; that is, the physiological requirements for nutrients necessary to maintain life or homeostasis addressed by foods for special dietary use are the same as those of normal, healthy persons. These foods are formulated in such a way that only the ingredients or physical form of the diet is different.20

On the other hand, the agency stated in the alternative interpretation that distinctive nutritional requirement may be construed to encompass physical and physiological limitations in a person's ability to ingest or digest conventional foods, as well as distinctive physiological nutrient requirements.21 Similarly, the Life Sciences Research Office of the Federation of American Societies for Experimental Biology (LSRO/FASEB Panel) noted in its 1990 Guidelines for the Scientific Review of Enteral Food Products for Special Medical Purposes that medical foods are for "patients with limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients contained therein, or (who) have other specialized medically determined nutrient requirements."22 After quoting this purpose, the FDA stated that the definition of distinctive nutritional requirement would include

foods intended for persons not able to ingest foods in certain physical forms (e.g., solid food), foods intended for persons who need a concentrated form of nutrition because of reduced appetite as a result of disease or convalescence, or foods intended for persons who may have other physical limitations on the amount or composition of food that they can consume. Although these types of conditions do not necessarily result in nutrient needs different from those of healthy persons, they represent a situation where it may be necessary that the food be formulated and manufactured within very narrow tolerances to ensure that the food provides most or all of the essential nutrients, as the person for whom the food is intended may not be able to eat a variety of foods to ensure that they meet their nutritional requirements.23

The second element that the FDA recognized as a distinguishing attribute of medical foods is the statutory requirement that a medical food be "formulated to be consumed or administered enterally under the supervision of a physician." As a general requirement, the patient must be receiving short- or long-term "active and ongoing" medical supervision (e.g., in a health care facility or as an outpatient).24 Unlike foods for special dietary purposes, the FDA views medical foods as an integral component of the patient's clinical management. Medical foods are not just simply recommended by a physician as a "part of an overall diet designed to reduce the risk of a disease or medical condition, to lose or maintain weight, or to ensure the consumption of a healthy diet."25

The final fundamental element of the definition of medical food addressed in the 1996 ANPR is the statutory requirement that a medical food be intended for the "specific dietary management" of a disease or condition. The FDA advised that the term "specific dietary management. . .evidences that Congress intended [medical] foods to be an integral part of the clinical treatment of patients."26 The agency also cited the LSRO/FASEB Panel's conclusion that the objective of incorporating the use of medical foods into patient management was, in part, to "ameliorate clinical manifestations of the disease," "favorably influence the disease process," and "positively influence morbidity and mortality (patient outcomes)."

Axona is an example of a medical food widely prescribed by physicians today. Axona, developed by Accera, is a medical food to provide the necessary nutrients for patients with Alzheimer's disease (AD). It has been clinically shown to improve cognitive function in some patients with AD, the leading cause of dementia, and does not increase metabolism. AD is a neurodegenerative disease characterized by a decline in the ability of the brain to metabolize glucose, even in its early stages. Axona is made from caprylic triglyceride and other medium chain triglycerides, which are converted to ketone bodies by the liver, an alternative energy source for cerebral neurons.

To read this article in full, please click here.

Originally published in the Nutraceutical and Functional Food Regulations in the United States and Around the World (Second Edition).


1 Advanced Notice of Proposed Rulemaking, Regulation of Medical Foods, 61 Fed. Reg. 60661, 60662 (Nov. 29, 1996).

2 The FDA recognized foods for "special dietary use" as early as 1941. Per regulation, the FDA stated that the term "special dietary uses" as applied to food for man, meant, among other things, "uses for supplying particular dietary needs which exist by reason of a physical, physiological, pathological or other condition, including but not limited to the conditions of disease, convalescence, pregnancy, lactation, allergic hypersensitivity to food, underweight, and overweight." Amendment to the General Regulations, Regulations for the Enforcement of the Federal Food, Drug, and Cosmetic Act, 6 Fed. Reg. 5921 (Nov. 22, 1941). This part of the regulation remains unchanged in the Code of Federal Regulations. See 21 C.F.R. y 105.3(a)(1) (September 17, 2013).

3 8 Fed. Reg. 2124, 2126 (January 19, 1973).

4 21 U.S.C. y 360ee(b)(3). Foods for special dietary use were often referred to as "orphan" because they were developed for the treatment of rare disorders that affect fewer than 200,000 persons in the United States. T.P. Labuza, Food Laws and Regulations: The Impact on Food Research, 36 Food Drug Cosmetic L.J. 293 (1981).

5 21 U.S.C. y 360ee(b)(3). The amendments also introduced a subcategory called "orphan medical foods" to be used in the management of ". . .any disease or condition that occurs so infrequently in the United States that there is no reasonable expectation that a medical food for such a disease or condition will be developed without assistance." Id.

6 61 Fed. Reg. 60662.

7 54 Fed. Reg. 32610 (August 8, 1989).

8 Virginia Wilkening, The Nutrition Labeling and Education Act of 1990 (November 27, 1991), http://www.nutrientdataconf.org/PastConf/NDBC17/8-2_Wilkening.pdf (last visited September 17, 2013).

9 55 Fed. Reg. 29456 (July 19, 1990).

10 Nutrition Labeling and Education Act y 2(a)(1990).

11 56 Fed. Reg. 60366 (November 27, 1991).

12 Id. at 60377.

13 Id.

14 Id., at 60378

15 58 Fed. Reg. 2079, 2151 (January 6, 1993).

16 21 C.F.R. y 101.9(j)(8).

17 58 Fed. Reg. 2151.

18 61 Fed. Reg. 60662.

19 69 Fed. Reg. 68834 (November 26, 2004). The FDA declared that: Because of competing priorities that have tied up FDA's limited resources, the agency has been unable to consider, in a timely manner, the issues raised by comments on the ANPRM, and does not foresee having sufficient resources in the near term to do so. Therefore, the agency is withdrawing this ANPRM. However, FDA believes that the basic principles described in the ANPRM provide an appropriate framework for understanding the regulatory paradigm governing medical foods. Therefore, FDA advises that it will continue to refer to the basic principles described in the ANPRM and in FDA's Medical Foods Compliance Program (CP 7321.002) when evaluating medical foods. With regard to the specific points made in the comment regarding regulation of medical foods, the comment is correct that the act exempts medical foods from the nutrition labeling, health claim and nutrient content claim requirements that are applicable to most other foods. However, all statements on food labels (including medical foods) must be truthful and not misleading (see section 403(a)(1) of the [A]ct). FDA advises that medical foods with false and misleading labeling are subject to enforcement action. The agency also advises that withdrawal of this ANPRM does not change the requirement that all ingredients used in medical foods must be approved food additive, GRAS, or otherwise exempt from the food additive definition. Medical foods that do not comply with this requirement are subject to enforcement action.

20 61 Fed. Reg. at 60667. The agency provided an example of a person possessing a special dietary need for a food that is in liquid form due to problems swallowing, noting that this special dietary need does not change his or her physiologic nutrient requirements. Along the same lines, a person allergic to gluten may need foods specially formulated, but the food would still provide the same amount of amino acids as needed by the general population because the quantitative and qualitative amount of overall protein required by the body is similar in both healthy and protein-sensitive individuals. Id.

21 Id.

22 J.M. Talbot, Guidelines for the Scientific Review of Enteral Food Products for Special Medical Purposes, Life Sciences Research Office, Federation of American Societies for Experimental Biology (1990).

23 61 Fed. Reg. at 60668.

24 Id. (citing 56 Fed. Reg. 60377).

25 Id., at 60668.

26 Id.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions